Emily Harless
Nurse Practitioner · Asheboro, NCNPI 1306227566
Payments from drug & device makers
Across 427 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$619
- AstraZeneca$262
- Pfizer$228
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$217
- Novo Nordisk$197
- plus $4K from 54 others
What the payments were for
- Food & beverage$6,62498%
- Education$1202%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,745 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 52 | $67,739 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 11 | $46,220 |
| FarxigaDapagliflozin Propanediol | 49 | $42,464 |
| MounjaroTirzepatide | 30 | $35,889 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 33 | $31,794 |
| RybelsusSemaglutide | 31 | $31,640 |
| JanuviaSitagliptin Phosphate | 30 | $24,537 |
| JardianceEmpagliflozin | 12 | $23,314 |
| TrulicityDulaglutide | 21 | $21,813 |
| XareltoRivaroxaban | 22 | $20,612 |
| EntrestoSacubitril/Valsartan | 20 | $20,445 |
| EliquisApixaban | 21 | $16,425 |
| BelsomraSuvorexant | 31 | $13,663 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $13,252 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $9,994 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $197 | $99,37983 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $262 | $79,454104 claims |
| Lilly USA, LLCMounjaro, Trulicity | $619 | $57,70251 claims |
| MerckJanuvia, Belsomra | $121 | $38,20161 claims |
| Boehringer IngelheimJardiance | $51 | $23,31412 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $164 | $23,24638 claims |
| Johnson & JohnsonXarelto | $188 | $20,61222 claims |
| NovartisEntresto | $114 | $20,44520 claims |
| PfizerEliquis | $228 | $16,42521 claims |
| Astellas Pharma US IncMyrbetriq | $147 | $9,41612 claims |
| Hikma Pharmaceuticals USAMitigare, Epinephrine | $30 | $2,70625 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Asheboro
- Sandrivette JohnsonRaleigh$573K
- Skyler RogersPinehurst$174K
- Jamie DinerDurham$170K
- Ayeshia WrightMocksville$145K
- Deborah AllenDurham$112K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
- Bridget ArchambaultDurham$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.